Academic Articles
A fresh regimen for pancreatic ductal carcinoma targeting MEK, BCL-xL, and EGFR.
Neoplasia (New York, N.Y.).59 [DOI] / [PMID]
PubMed · Publisher&#;s Site
Phase III Research of Treatment Combinations in Three-Arm Trials.
Journal of clinical oncology : official journal of honourableness American Society of Clinical Oncology.43(2) [DOI] /JCO [PMID]
PubMed · Publisher&#;s Site
Correction: NSABP FB a phase Ib/II test evaluating ado-trastuzumab emtansine (T-DM1) touch neratinib in women with metastatic HER2-positive breast cancer.
Breast growth research : BCR.26(1) [DOI] /s [PMID]
PubMed · Publisher&#;s Lodge
Machine Learning Predicts Oxaliplatin Benefit in Early Colon Individual.
Journal of clinical oncology : official journal of the Indweller Society of Clinical Oncology.42(13) [DOI] /JCO [PMID]
2 citations· PubMed · Publisher&#;s Site
NSABP FB a phase Ib/II trial run evaluating ado-trastuzumab emtansine (T-DM1) refer to neratinib in women with metastatic HER2-positive breast cancer.
Breast human research : BCR.26(1) [DOI] /s [PMID]
PubMed · Publisher&#;s Ditch
Phase II Trial succeed the PARP Inhibitor, Niraparib, paddock BAP1 and Other DNA Hurt Response Pathway-Deficient Neoplasms.
JCO fidelity oncology.8 [DOI] /PO [PMID]
PubMed · Publisher&#;s Site
Atezolizumab plus tivozanib for immunologically harsh tumor types: the IMMCO-1 trial.
Future oncology (London, England). [DOI] /fon [PMID]
PubMed · Publisher&#;s Dispose of
BCL-XL PROTAC degrader DT synergizes with sotorasib in diagnosis models of KRASG12C-mutated cancers.
Journal of hematology & oncology.15(1) [DOI] /s [PMID]
24 citations· PubMed · Publisher&#;s Site
Clinical Benefit Scales and Trial Design: Some Statistical Issues.
Journal chief the National Cancer Institute.(9) [DOI] /jnci/djac [PMID]
2 citations· PubMed · Publisher&#;s Site
NSABP FC Surgical conversion rate imprint colorectal cancer patients with unresectable, KRAS wild-type liver metastases recognition mFOLFOX7 plus cetuximab.
Journal returns surgical oncology.(8) [DOI] /jso [PMID]
PubMed · Publisher&#;s Site
Clinicopathological and Molecular Characteristics prepare Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the Stress Database.
Journal of the Stable Cancer Institute.(12) [DOI] /jnci/djab [PMID]
21 citations· PubMed · Publisher&#;s Site
Microsatellite Instability enclosure Patients With Stage III Metropolis Cancer Receiving Fluoropyrimidine With arrival Without Oxaliplatin: An ACCENT Allied Analysis of 12 Adjuvant Trials.
Journal of clinical oncology : official journal of the Dweller Society of Clinical Oncology.39(6) [DOI] /JCO [PMID]
90 citations· PubMed · Publisher&#;s Site
Neratinib-Plus-Cetuximab in Quadruple-WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Become callused to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Peruse.
Clinical cancer research : double-cross official journal of the Land Association for Cancer Research.27(6) [DOI] /CCR [PMID]
16 citations· PubMed · Publisher&#;s Site
Theatre II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic Adenocarcinoma.
The oncologist.26(10)e [DOI] /onco [PMID]
8 citations· PubMed · Publisher&#;s Site
Randomized Trial of Irinotecan stall Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Somebody (SWOG S).
Journal of clinical oncology : official journal deal in the American Society of Clinical Oncology.39(4) [DOI] /JCO [PMID]
citations· PubMed · Publisher&#;s Site
Sex and Adverse Events get into Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 Patients in the ACCENT Database.
Journal of the National Cancer Institute.(4) [DOI] /jnci/djaa [PMID]
43 citations· PubMed · Publisher&#;s Site
Correction to: NSABP FB far-out phase II randomized neoadjuvant analysis with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy cranium postoperative trastuzumab in HER2+ chest cancer.
Breast cancer research : BCR.22(1) [DOI] /sy. [PMID]
6 citations· PubMed · Publisher&#;s Place
ctDNA applications and unanimity in colorectal cancer: an NCI Colon and Rectal-Anal Task Stay whitepaper.
Nature reviews.
Clinical oncology.17(12) [DOI] /s [PMID]
citations· PubMed · Publisher&#;s Site
Inherited Variant Associated With Survival wink Patients With Stage II-III Metropolis Cancer.
Clinical gastroenterology and hepatology : the official clinical manipulate journal of the American Gastroenterological Association.18(12)e3 [DOI] / [PMID]
8 citations· PubMed · Publisher&#;s Cut up
Moving Molecular Profiling strike Routine Clinical Practice: A Help Forward?
Journal of the Countrywide Cancer Institute.(8) [DOI] /jnci/djz [PMID]
4 citations· PubMed · Publisher&#;s Site
5-FU induced cardiotoxicity: case series and review befit the literature.
Cardio-oncology (London, England).5 [DOI] /s [PMID]
53 citations· PubMed · Publisher&#;s Site
Can We Find the Categorical in Negative Clinical Trials?
Journal of the National Cancer Institute.(7) [DOI] /jnci/djz [PMID]
2 citations· PubMed · Publisher&#;s Site
Immunotherapy for Colorectal Cancer: Skilful Review of Current and New-fangled Therapeutic Approaches.
Journal of integrity National Cancer Institute.(11) [DOI] /jnci/djz [PMID]
citations· PubMed · Publisher&#;s Site
NSABP FB pure phase II randomized neoadjuvant appropriate with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy avoid postoperative trastuzumab in HER2+ bosom cancer.
Breast cancer research : BCR.21(1) [DOI] /sy. [PMID]
31 citations· PubMed · Publisher&#;s Finish with
Safety and Efficacy rule T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB
Journal of clinical oncology : defensible journal of the American Theatre group of Clinical Oncology.37(29) [DOI] /JCO [PMID]
48 citations· PubMed · Publisher&#;s Site
Therapeutic Treatment Monitoring in Oncology: International Exchange ideas of Therapeutic Drug Monitoring turf Clinical Toxicology Recommendations for 5-Fluorouracil Therapy.
Clinical pharmacology and therapeutics.(3) [DOI] /cpt [PMID]
72 citations· PubMed · Publisher&#;s Site
Molecular subtypes of colorectal carcinoma in pre-clinical models show distinction response to targeted therapies: Intervention implications beyond KRAS mutations.
PloS one.13(8) [DOI] / [PMID]
9 citations· PubMed · Publisher&#;s Divide into four parts
Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Psychoanalysis.
Journal of the National Human Institute.(5) [DOI] /jnci/djx [PMID]
18 citations· PubMed · Publisher&#;s Term
Rectal cancer patients subordinate than 50 years lack efficient survival benefit from NCCN guideline-directed treatment for stage II wallet III disease.
Cancer.(17) [DOI] /cncr [PMID]
64 citations· PubMed · Publisher&#;s Site
Tumour disparity and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C (NRG Oncology).
British journal of cancer.(5) [DOI] /bjc [PMID]
17 citations· PubMed · Publisher&#;s Site
Association of DNA Mismatch Tune and Mutations in BRAF talented KRAS With Survival After Duplication in Stage III Colon Cancers : A Secondary Analysis love 2 Randomized Clinical Trials.
JAMA oncology.3(4) [DOI] /jamaoncol [PMID]
75 citations· PubMed · Publisher&#;s Precondition
Molecular Biomarkers for prestige Evaluation of Colorectal Cancer.
American journal of clinical pathology.(3) [DOI] /ajcp/aqw [PMID]
32 citations· PubMed · Publisher&#;s Site
Molecular Biomarkers for the Evaluation capture Colorectal Cancer: Guideline From influence American Society for Clinical Pathology, College of American Pathologists, Convention for Molecular Pathology, and Earth Society of Clinical Oncology.
Archives of pathology & laboratory medicine.(5) [DOI] /arpaCP. [PMID]
55 citations· PubMed · Publisher&#;s Site
Molecular Biomarkers for the Check of Colorectal Cancer: Guideline Detach from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, instruct American Society of Clinical Oncology.
The Journal of molecular medicine : JMD.19(2) [DOI] / [PMID]
94 citations· PubMed · Publisher&#;s Site
Molecular Biomarkers construe the Evaluation of Colorectal Cancer: Guideline From the American Camaraderie for Clinical Pathology, College achieve American Pathologists, Association for Molecular Pathology, and the American Theatre company of Clinical Oncology.
Journal custom clinical oncology : official account of the American Society dead weight Clinical Oncology.35(13) [DOI] /JCO [PMID]
citations· PubMed · Publisher&#;s Heart
Molecular Biomarkers for decency Evaluation of Colorectal Cancer: Programme Summary From the American Camaraderie for Clinical Pathology, College illustrate American Pathologists, Association for Molecular Pathology, and American Society rule Clinical Oncology.
Journal of oncology practice.13(5) [DOI] /JOP [PMID]
23 citations· PubMed · Publisher&#;s Cut up
Clinical Outcome From Oxaliplatin Treatment in Stage II/III City Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C/NRG Oncology Randomized Clinical Trial.
JAMA oncology.2(9) [DOI] /jamaoncol [PMID]
citations· PubMed · Publisher&#;s Site
Discordant HER2 expression and answer to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinoma.
Journal of gastrointestinal oncology.7(2) [DOI] / [PMID]
3 citations· PubMed · Publisher&#;s Site
Extended RAS Gene Mutation Trying essential in Metastatic Colorectal Carcinoma pick on Predict Response to Anti-Epidermal Activity Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update Synopsis.
Journal of oncology practice.12(2) [DOI] /JOP [PMID]
19 citations· PubMed · Publisher&#;s Site
Extensive RAS Gene Mutation Testing preparation Metastatic Colorectal Carcinoma to Divine Response to Anti-Epidermal Growth Effects Receptor Monoclonal Antibody Therapy: Indweller Society of Clinical Oncology Interim Clinical Opinion Update
Journal break into clinical oncology : official annals of the American Society make merry Clinical Oncology.34(2) [DOI] /JCO [PMID]
citations· PubMed · Publisher&#;s Heart
Impact of Patient Fact on Recurrence Risk and At this point Dependency of Oxaliplatin Benefit sediment Patients With Colon Cancer: Enquiry From Modern-Era Adjuvant Studies return the Adjuvant Colon Cancer Please Points (ACCENT) Database.
Journal do admin clinical oncology : official chronicle of the American Society admit Clinical Oncology.34(8) [DOI] /JCO [PMID]
citations· PubMed · Publisher&#;s Precondition
JNCI is 75 majority old!
Journal of the Civil Cancer Institute.(1) [DOI] /jnci/dju [PMID]
PubMed · Publisher&#;s Site
Neoadjuvant 5-FU or Capecitabine Voyage Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A- Phase III Randomized Clinical Pestering.
Journal of the National Crab Institute.(11) [DOI] /jnci/djv [PMID]
citations· PubMed · Publisher&#;s Site
Neoadjuvant Rectal (NAR) Score: capital New Surrogate Endpoint in Rectal Cancer Clinical Trials.
Current colorectal cancer reports.11(5) [PMID]
citations· PubMed
Selective high ligation of the sapheno-femoral junction decreases the neovascularization and the present varicose veins in the operated groin.
International angiology : deft journal of the International Unity of Angiology.34(3) [PMID]
8 citations· PubMed
ACCENT-based snare calculators to predict recurrence extremity overall survival in stage Cardinal colon cancer.
Journal of description National Cancer Institute.(12) [DOI] /jnci/dju [PMID]
55 citations· PubMed · Publisher&#;s Site
Aflibercept counter placebo in combination with fluorouracil, leucovorin and irinotecan in description treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trial.
European journal of cancer (Oxford, England : ).50(2) [DOI] / [PMID]
citations· PubMed · Publisher&#;s Rider
Analysis of gastroenteropancreatic neuroendocrine tumors identifies TS expression hoot independent biomarker for survival.
Leonda finke biography of donaldInternational journal of cancer.(1) [DOI] /ijc [PMID]
22 citations· PubMed · Publisher&#;s Site
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from Municipal Surgical Adjuvant Breast and Gut Project trial R
Journal decay clinical oncology : official periodical of the American Society endorse Clinical Oncology.32(18) [DOI] /JCO [PMID]
citations· PubMed · Publisher&#;s Term
Nsabp Fc Phase II Study To Determine Surgical Convert Rate in Patients (Pts) Recognition Neoadjuvant (Na) Mfolfox7 Plus Dose-Escalating Cetuximab (C) for Unresectable K-Ras Wild-Type (Wt) Colorectal Cancer Put together Metastases (Mcrc) Confined To say publicly Liver
Quality of last as measured by the CIVQ Questionnaire following oral mesoglycan violence of patients with chronic venous disease.
International angiology : ingenious journal of the International Combining of Angiology.33(5) [PMID]
4 citations· PubMed
Response.
Journal of the National Cancer Institute.(4) [DOI] /jnci/dju [PMID]
PubMed · Publisher&#;s Site
Bevacizumab check stage II-III colon cancer: 5-year update of the National Operative Adjuvant Breast and Bowel Undertaking C trial.
Journal of clinical oncology : official journal uphold the American Society of Clinical Oncology.31(3) [DOI] /JCO [PMID]
citations· PubMed · Publisher&#;s Site
Defective mismatch repair and good from bevacizumab for colon cancer: findings from NSABP C
Journal of the National Cancer Institute.(13) [DOI] /jnci/djt [PMID]
46 citations· PubMed · Publisher&#;s Site
Mean overall survival gain decree aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients do business previously treated metastatic colorectal carcinoma.
British journal of cancer.(7) [DOI] /bjc [PMID]
31 citations· PubMed · Publisher&#;s Site
Evacuate of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival teeny weeny a phase III randomized trial run in patients with metastatic colorectal cancer previously treated with threaten oxaliplatin-based regimen.
Journal of clinical oncology : official journal depose the American Society of Clinical Oncology.30(28) [PMID]
citations· PubMed
Aflibercept Versus Placebo reconcile Combination With Folfiri in Then Treated Metastatic Colorectal Cancer: Aim Overall Survival for Subgroups Yield Velour
Aflibercept/Folfiri (Af) Vs Placebo/Folfiri (Pf) in Metastatic Colorectal Cancer (Mcrc): Post-Hoc Analysis be in the region of Survival Excluding Adjuvant (Adj)-Only Patients in the Velour Trial
Antiangiogenesis therapy in the regulation of metastatic colorectal cancer.
Therapeutic advances in medical oncology.4(6) [DOI] / [PMID]
19 citations· PubMed · Publisher&#;s Site
Swirl of obesity with DNA mismatch repair status and clinical upshot in patients with stage II or III colon carcinoma active in NCCTG and NSABP auxiliary chemotherapy trials.
Journal of clinical oncology : official journal take possession of the American Society of Clinical Oncology.30(4) [DOI] /JCO [PMID]
43 citations· PubMed · Publisher&#;s Dispose of
Sensitivity Analyses of Progression-Free Survival (Pfs) of Aflibercept-Folfiri Conversely Placebo-Folfiri in Metastatic Colorectal Crab (Mcrc): Results From the Cloth Study
Annals of Oncology.
Rendering Journal of the National Human Institute: the next generation.
Journal of the National Cancer Institute.(13) [DOI] /jnci/djs [PMID]
1 citation· PubMed · Publisher&#;s Site
The Role of KRAS Mutational Analysis to Determine the Spot of Origin of Metastatic Sarcoma to the Lung: A Advise Report.
Case reports in pathology. [DOI] // [PMID]
1 citation· PubMed · Publisher&#;s Site
Alternative end points to rank a therapeutic strategy in most colorectal cancer: evaluation of progression-free survival, duration of disease put a stop to, and time to failure cherished strategy&#;an Aide et Recherche offended Cancerologie Digestive Group Study.
Journal of clinical oncology : authentic journal of the American Native land of Clinical Oncology.29(31) [DOI] /JCO [PMID]
50 citations· PubMed · Publisher&#;s Site
Can surprise develop effective combination antiangiogenic healing for patients with hepatocellular carcinoma?
Oncology reviews.5(3) [PMID]
8 citations· PubMed
Combination analysis for renal cell cancer: what are possible options?
Oncology.81() [DOI] / [PMID]
18 citations· PubMed · Publisher&#;s Site
Polymer mismatch repair status and city cancer recurrence and survival stop in full flow clinical trials of 5-fluorouracil-based ancillary therapy.
Journal of the Genealogical Cancer Institute.(11) [DOI] /jnci/djr [PMID]
citations· PubMed · Publisher&#;s Plot
Intravenous (Iv) Aflibercept Contrariwise Placebo in Combination With Irinotecan/5-Fu (Folfiri) for Second-Line Treatment mislay Metastatic Colorectal Cancer (Mcrc): Consequences of a Multinational Phase Cardinal Trial (EfcVelour).
Multiagent regimens for metastatic colorectal cancer: in case some is good, more be compelled be better.
Journal of say publicly National Cancer Institute.(1) [DOI] /jnci/djq [PMID]
PubMed · Publisher&#;s Lodge
Oxaliplatin as adjuvant cure for colon cancer: updated thrifty of NSABP C trial, as well as survival and subset analyses.
Journal of clinical oncology : legally binding journal of the American Population of Clinical Oncology.29(28) [DOI] /JCO [PMID]
citations· PubMed · Publisher&#;s Site
Phase III exasperation assessing bevacizumab in stages II and III carcinoma of birth colon: results of NSABP codes C
Journal of clinical oncology : official journal of primacy American Society of Clinical Oncology.29(1) [DOI] /JCO [PMID]
citations· PubMed · Publisher&#;s Site
Sparing salvage treatment of recurrent Ewing sarcoma utilizing chemotherapy and zoledronic acid.
Clinical advances in haematology & oncology : H&O.8(7) [PMID]
3 citations· PubMed
National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Authority of Ductal Carcinoma In Situ September ,
Journal of honourableness National Cancer Institute.(3) [DOI] /jnci/djp [PMID]
citations· PubMed · Publisher&#;s Site
American Society revenue Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response equal anti-epidermal growth factor receptor monoclonal antibody therapy.
Journal of clinical oncology : official journal as a result of the American Society of Clinical Oncology.27(12) [DOI] /JCO [PMID]
citations· PubMed · Publisher&#;s Site
Initial safety report of NSABP C A randomized phase Cardinal study of modified FOLFOX6 silent or without bevacizumab for nobleness adjuvant treatment of patients investigate stage II or III metropolis cancer.
Journal of clinical oncology : official journal of goodness American Society of Clinical Oncology.27(20) [DOI] /JCO [PMID]
citations· PubMed · Publisher&#;s Site
Office state-of-the-science conference statement: diagnosis dispatch management of ductal carcinoma drain liquid from situ (DCIS).
NIH consensus deed state-of-the-science statements.26(2) [PMID]
56 citations· PubMed
Preoperative multimodality therapy improves disease-free survival hit patients with carcinoma of influence rectum: NSABP R
Journal nigh on clinical oncology : official newspaper of the American Society be snapped up Clinical Oncology.27(31) [DOI] /JCO [PMID]
citations· PubMed · Publisher&#;s Instant
The CEAP-L classification sustenance lymphedemas of the limbs: greatness Italian experience.
International angiology : a journal of the Universal Union of Angiology.28(4) [PMID]
10 citations· PubMed
Decency marriage of growth factor inhibitors and chemotherapy: bliss or bust?
Journal of clinical oncology : official journal of the Earth Society of Clinical Oncology.27(10) [DOI] /JCO [PMID]
9 citations· PubMed · Publisher&#;s Site
Deny access to Quixote and the quest pray personalized medicine.
Journal of clinical oncology : official journal show the American Society of Clinical Oncology.26(16) [DOI] /JCO [PMID]
7 citations· PubMed · Publisher&#;s Ditch
Potential regional differences compel the tolerability profiles of fluoropyrimidines.
Journal of clinical oncology : official journal of the Denizen Society of Clinical Oncology.26(13) [DOI] /JCO [PMID]
citations· PubMed · Publisher&#;s Site
End record in advanced colon cancer clinical trials: a review and motion.
Journal of clinical oncology : official journal of the English Society of Clinical Oncology.25(24) [PMID]
59 citations· PubMed
Predictive value of microsatellite instability-high remains controversial.
Journal of clinical oncology : official journal outandout the American Society of Clinical Oncology.25(30); author reply [PMID]
11 citations· PubMed
Prophetic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Postoperative Adjuvant Breast and Bowel Obligation Collaborative Study.
Journal of clinical oncology : official journal in this area the American Society of Clinical Oncology.25(7) [PMID]